News: Novitas Capital

PA Early Stage Announces First Closing on Fund III

(continued)

 

Under the leadership of Schmitt, PA Early Stage has built a strong portfolio of life sciences companies across a broad range of segments, including medical devices, drug development, diagnostics, ag-biotech, and healthcare delivery systems. Schmitt commented, "We are particularly pleased that several of these companies, including MedCases, PlantGenix, and Neuronyx, have already attracted high-quality investments from national life science venture funds or partnerships with leading pharmaceutical companies and corporations."

 

 

 

 

"One of the key factors contributing to the success of PA Early Stage is its focus on Pennsylvania," added McCord. "When you take a close look at the universities, research centers, IT and pharmaceutical companies, and various support activities – like the Greenhouses and Ben Franklin Centers – it is clear that Pennsylvania is technology-rich and ideal for the creation of strong early stage companies."

 

About PA Early Stage

PA Early Stage is a family of venture funds that makes investments in early stage information technology and life sciences companies. With over $200 million under management, PA Early Stage invests in companies that are primarily based in the Mid-Atlantic region, with a focus on Pennsylvania. The fund can be found on the Web at www.paearlystage.com.

Page: 1 2